emerging markets
Huge increase in emerging market spending to lift pharma
July 16, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, IMS, emerging markets, pharmerging
The global pharmaceutical market is set to return to stronger growth of 5-7% by 2016, according to a new forecast. …
Eisai to enter Russia with epilepsy launch
June 27, 2012Sales and Marketing Eisai, Russia, Zonegran, emerging markets, epilepsy
Eisai is to enter the Russian market for the first time with the launch of epilepsy drug Zonegran. Entry into the …
Access to new cancer drugs limited in Brazil and Mexico
April 13, 2012Sales and Marketing Brazil, Cancer, Mexico, avastin, emerging markets
Between one-quarter and one-third of patients in Brazil and Mexico who are eligible for treatment with new cancer drugs do …
Innovating in China’s pharma market
April 12, 2012Research and Development AstraZeneca, China, R&D, Steve Yang, emerging markets
The challenges that China and the wider Asia region face in healthcare represent big opportunities for multinational pharma companies. Cases of …
India’s Nexavar patent ruling disturbs pharma
March 12, 2012Sales and Marketing India, emerging markets, intellectual property, patents
India is to allow Bayer’s cancer treatment Nexavar to be subject to a compulsory licence, allowing a generic firm to …
Merck unveils Brazilian joint venture
February 17, 2012Sales and Marketing Brazil, Merck & Co, Supera Farma, emerging markets
Merck Inc has bolstered its presence in emerging markets by entering a joint venture with Brazilian firm Supera Farma Laboratorios. Due …
Quintiles launches new Asian market service
February 13, 2012Research and Development Asia, Quintiles, emerging markets
Contract research and consulting firm Quintiles has launched two new services to help pharma improve their chances of developing and …
Lucentis approved in China
January 18, 2012Sales and Marketing China, Galvus, Lucentis, Novartis, em, emerging markets
Novartis’ eye treatment Lucentis has gained approval in China, and the firm has also launched its diabetes drug Galvus in …
2011 Year In Review
January 6, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2011, Europe, emerging markets, year in review
A round up of some of the key themes in pharma’s yearEUROPE IN CRISIS While the Eurozone has averted meltdown …
GSK faces fine over Argentina clinical trial
January 6, 2012Research and Development, Sales and Marketing Argentina, GSK, Vaccine, deaths, emerging markets
A court in Argentina says GSK should be fined for irregularities in recruitment during a trial in which children died. …
BMS in cholesterol alliance with China’s Simcere
December 16, 2011Sales and Marketing BMS, CETP inhibitor, Simcere, cardiovascular, emerging markets
Bristol-Myers Squibb is to co-develop a new compound to treat cardiovascular disease with Chinese firm Simcere Pharmaceutical Group. The companies, …
Bayer forecasts €11 billion growth in Asia
November 17, 2011Bayer, China, emerging markets
Bayer is expecting sales in Asia to grow by €11 billion over the next four years, with over half of …
Emerging markets help Bayer through tough quarter
October 28, 2011Sales and Marketing Bayer, Xarelto, emerging markets
Bayer has posted modest results for the third quarter, with growth in emerging markets compensating for austerity measures in Europe …
Lundbeck establishes research centre in China
October 18, 2011Research and Development Brain disorders, CNS, China, Lundbeck, Shanghai, emerging markets
Lundbeck has set up a new research centre in China, joining a wave of pharma companies investing in the region. The …
Actavis plans ‘major’ sales expansion in Latin America
October 6, 2011Sales and Marketing Actavis, emerging markets, generics
Swiss company Actavis has launched a new business unit to target the fast-growing Latin American generics market. Mirroring the branded …
